1. Moretti JM, Tamgac F, Weinmann P, Caillat-Vigneron N, Belin CA, Cesaro P, et al. Early and delayed brain SPECT with technetium-99m-ECD and iodine-123-IMP in subacute strokes.J Nucl Med 35: 1444–1449, 1994.
2. Walovitch RC, Chesman EH, Maheu LJ, Hall KM. Studies of the retention mechanism of the brain perfusion imaging agent99mTc-Bicisate (99mTc-ECD).J Cereb Blood Flow Metab 14: S4-S11, 1994.
3. Ichise M, Golan H, Ballinger JR, Vines D, Blackman A, Moldofsky H. Regional difference in technetium-99m-ECD clearance on the brain SPECT in healthy subjects.J Nucl Med 38: 1253–1260, 1997.
4. Walovitch RC, Franceschi M, Picard M, Cheesman EH, Hall KM, Makuch J, et al. Metabolism of99mTc-L, L-Ethyl cysteinate dimer in healthy volunteers.Neuropharmacology 30: 283–292, 1991.
5. Lévéillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, et al. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 2: biodistribution and brain imaging in humans.J Nucl Med 30: 1902–1910, 1989.